Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Enveric Biosciences, Inc. (ENVB) vs Lexaria Bioscience Corp. (LEXX)

Enveric Biosciences, Inc. and Lexaria Bioscience Corp. are both Biotechnology companies. Enveric Biosciences, Inc. and Lexaria Bioscience Corp. are of similar size ($7.1M and $6.9M). Lexaria Bioscience Corp. grew revenue faster over the last twelve months: 9.08% against −13.9%. Across the 13 metrics below, Lexaria Bioscience Corp. leads on 8 and Enveric Biosciences, Inc. on 5.

Valuation

Metric ENVB LEXX Biotechnology median
P/E n/m n/m 7.88
P/S 0.17 10.01 11.47
P/B 0.74 1.25 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA 0.25 n/m 0.74
EV/Sales (0.06) 3.66 10.73
Earnings yield (442.99%) (155.41%) (28.84%)
Free cash flow yield (178.32%) (138.70%) (23.03%)

Profitability

Metric ENVB LEXX Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (235.48%) (162.60%) (57.72%)
Return on assets (193.53%) (134.20%) (49.22%)
Return on invested capital 0.00% (662.56%) 0.00%

Growth

Metric ENVB LEXX Biotechnology median
Revenue growth (TTM) (13.93%) 9.08% 5.64%
EPS growth (last fiscal year) 84.14% (40.43%) —
Revenue growth, 5-year CAGR — 17.53% 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ENVB LEXX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 10.21 10.60 4.73
Net debt to EBITDA 0.55 0.17 0.96

Dividend

Metric ENVB LEXX Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric ENVB LEXX Biotechnology median
Market cap 6.92m 7.10m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack